Related Experiment Video
Updated: Jun 19, 2026

Video Tracking Protocol to Screen Deterrent Chemistries for Honey Bees
Published on: June 12, 2017
[Prevention with repellent in children]
1Groupe de Pédiatrie Tropicale (GPTrop), Société Française de Pédiatrie, Département de Pédiatrie, Hôpital Saint Vincent de Paul, 82 boulevard Denfert-Rochereau, 75014 Paris, France. freedso@gmail.com
Insights
Topical insect repellents protect children from vector-borne diseases like Lyme and malaria. Parents should follow age-specific application guidelines for safe and effective use, considering long-term exposure risks.
Area of Science:
- Public Health
- Pediatrics
- Dermatology
Context:
- Topical insect repellents are crucial for preventing arthropod-borne diseases.
- Effective prevention involves repellents, treated clothing, and netting.
- Parental education on safe repellent use is vital for children's health.
Purpose:
- To provide guidelines for the rational prescription and use of topical insect repellents in children.
- To assess the benefit-risk ratio of repellents considering age, concentration, and application frequency.
- To address the knowledge gap in chronic/sub-chronic toxicity of repellents in pediatric populations.
Summary:
- Four main repellents (PMD, DEET, Icaridine, IR3535) are recommended, with 20% concentration effective for 3 hours.
- Mild side effects (dermatitis, allergy) are common; severe risks are linked to DEET misuse.
- French guidelines recommend specific daily applications based on age: once daily for infants >6 months, twice daily for ages 1-12, and thrice daily for >12 years.
Impact:
- Ensures appropriate and safe use of insect repellents in children, reducing disease transmission.
- Promotes informed decision-making for parents and healthcare providers regarding repellent use.
- Highlights the need for further research into the long-term safety of topical repellents in children.
Abstract:
Use of topical insect repellent is an important component in prophylaxis of arthropod bite vector borne diseases. Topical insect repellent are used in a three part management regimen, along with impregnated clothing and mosquito netting. Parental training for efficacious and secure use of repellents for their children is essential part of a successful strategy to combat Lyme borreliosis, dengue fever, Chikungunya, West Nile virus infection and malaria, amongst children, according to local epidemiological risks. Rational repellent prescription for a child must take into account age, active substance concentration, topical substance tolerance, nature and surface of the skin to protect, number of daily applications, and the length of use in a benefit-risk ratio assessment perspective. The 4 currently repellents recommended by Whopes (Who) for their long lasting efficacy and patient tolerance are: 1) Citriodiol (PMD), 2) DEET, 3) Icaridine (KB3023), and 4) IR3535. In field trials the minimum required concentration of each four of these agents to be effective for 3 hours against most arthropods is 20% (in cream, roll-on or spray vehicle). Described side effects of these agents are mild, being limited to local irritative dermatitis and allergy. The risk of severe side effects has been related to DEET misused and neurotoxicity. The international recommendations concerning utilization of topical repellent amongst children for prophylaxis of arthropod borne diseases is concerning short term usage (several weeks). But the use of repellent is sub chronic or chronic amongst the majority of children living in subtropical regions where these vector borne diseases are endemic. And toxicity of topical repellent when used sub-chronically and chronically is not well studied in pediatric age groups. Taking into account these considerations, the current recommendations of the French Group of Tropical Paediatrics are to teach the parents of children who live in arthropod vector disease endemic regions to use topical insect repellent on their children with the recommended age related frequency in the following way: the use of topical repellent in infants above 6 months, once daily. Only in exceptional circumstances of severe arthropod exposure risk, their brief use in nursing infants as young as 2 months is acceptable, however with never more than 1 application daily. From ages 1 to 12 years, 2 applications daily may be safely used; 3 applications daily after 12 years old through adulthood.
Related Concept Videos
Smallpox
Prevention of Further Absorption of Poison
Respiratory Syncytial Virus Disease
Preventive Healthcare Services
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
